Latest Insider Transactions at Humanigen, Inc (HGEN)
This section provides a real-time view of insider transactions for Humanigen, Inc (HGEN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HUMANIGEN, INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HUMANIGEN, INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 05
2013
|
Mpm Bioventures Iii Qp L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
5,265,856
+24.79%
|
-
|
|
Feb 05
2013
|
Luke Evnin > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,632,928
+24.79%
|
-
|
|
Feb 05
2013
|
Singapore Bio Innovations Pte LTD > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
472,013
+49.89%
|
-
|
|
Feb 05
2013
|
Lehman Brothers Holdings Inc. |
BUY
Conversion of derivative security
|
Indirect |
1,067,059
+50.0%
|
-
|
|
Feb 05
2013
|
James Healy Director |
BUY
Conversion of derivative security
|
Indirect |
1,765,117
+18.36%
|
-
|
|
Feb 05
2013
|
Sofinnova Venture Partners V LP > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
1,765,117
+18.36%
|
-
|
|
Feb 05
2013
|
Development Bank Of Japan Inc. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
491,530
+50.0%
|
-
|
|
Feb 05
2013
|
Baxter International Inc > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
958,583
+50.0%
|
-
|
|
Feb 05
2013
|
Mitsubishi Ufj Capital Ii, Limited Partnership > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
393,223
+50.0%
|
-
|
|
Feb 05
2013
|
5 Am Partners LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
498,038
+40.85%
|
-
|
|
Feb 05
2013
|
Alloy Ventures 2000, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
1,683,817
+49.88%
|
-
|
|
Feb 05
2013
|
Gbs Venture Partners Pty, LTD > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
825,613
+49.25%
|
-
|
|
Feb 05
2013
|
Brigitte Smith Director |
BUY
Conversion of derivative security
|
Indirect |
825,613
+49.25%
|
-
|
|
Jan 31
2013
|
Sanofi |
BUY
Open market or private purchase
|
Indirect |
87,500
+13.13%
|
$700,000
$8.0 P/Share
|
|
Jan 31
2013
|
James Healy Director |
BUY
Open market or private purchase
|
Indirect |
375,000
+48.97%
|
$3,000,000
$8.0 P/Share
|
|
Jan 31
2013
|
5 Am Partners LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
62,500
+21.88%
|
$500,000
$8.0 P/Share
|
|
Jan 31
2013
|
Brigitte Smith Director |
BUY
Open market or private purchase
|
Indirect |
25,000
+50.0%
|
$200,000
$8.0 P/Share
|
|
Jan 31
2013
|
Gbs Venture Partners Pty, LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
25,000
+50.0%
|
$200,000
$8.0 P/Share
|